Drug Trial Radar · NCT04022304
Comparision of Pharmacokinetic and Pharmacodynamic of Biocon Insulin N and Humulin® N
Last checked: Nov 20, 2026Latest source record: Jan 30, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
90
Actual
Start
Jun 15, 2019
Primary completion
Dec 21, 2019
Study completion Dec 27, 2019
Sponsor
- Lead sponsor
- Biocon LimitedIndustry
- Sponsor type
- Industry
- Collaborators
- Profil Institut für Stoffwechselforschung GmbH
- First posted
- Jul 17, 2019
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Other
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 55 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Single-centre, randomised, double-blind, three-period, six-sequence, partially replicated design, crossover trial in healthy subjects
Conditions
- Healthy Volunteer
Interventions
Biocon Insulin NBiological
Biocon Insulin N is an intermediate-acting isophane suspension of human insulin produced by recombinant deoxyribonucleic acid(rDNA) technology utilizing Pichia pastoris (yeast).
Humulin® NBiological
Humulin® N (human insulin \[recombinant deoxyribonucleic acid origin\] isophane suspension) is an intermediate-acting human isophane insulin. Humulin® N is a suspension of crystals produced from combining human insulin and protamine sulphate.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Primary PK endpoint: area under the insulin concentration curve(AUCins).0-24hTime frame: 0-24hour
- Primary PK endpoint: maximum observed insulin concentration(Cins.max)Time frame: 0-24hour
- PD endpoint:area under the glucose infusion rate curve(AUCGIR)0-24hTime frame: 0-24hour
- PD endpoint:maximum observed glucose infusion rate (GIRmax)Time frame: 0-24hour
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Profil Institut für Stoffwechselforschung GmbH
Neuss, Germany
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.